Systemic lupus erythematosus diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Systemic lupus erythematosus}} {{CMG}}; {{AE}}{{MIR}} ==Overview== ==Diagnostic criteria== ==References== {{reflist|2}}")
 
Line 5: Line 5:


==Diagnostic criteria==
==Diagnostic criteria==
SLICC criteria for the classification of systemic lupus erythematosus
# Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.
# Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40:1725.
# Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677.
{| class="wikitable"
!
!Criterion
!Definition
|-
|Clinical criteria
|Acute cutaneous lupus
|
* Lupus malar rash (do not count if malar discoid)
* Bullous lupus
* Toxic epidermal necrolysis variant of SLE
* Maculopapular lupus rash
* Photosensitive lupus rash (in the absence of dermatomyositis); '''OR''' subacute cutaneous lupus (nonindurated psoriaform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias)
|-
|
|Chronic cutaneous lupus
|
* Classic discoid rash
** Localized (above the neck)
** Generalized (above and below the neck)
** Hypertrophic (verrucous) lupus
** Lupus panniculitis (profundus)
** Mucosal lupus
** Lupus erythematosus tumidus
** Chilblains lupus OR
** Discoid lupus/lichen planus overlap
|-
|
|Nonscarring alopecia
|
* Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as alopecia areata, drugs, iron deficiency, and androgenic alopecia)
|-
|
|Oral or nasal ulcers
|
* Palate, buccal, tongue, or nasal ulcers (in the absence of other causes, such as vasculitis, Behçet's disease, infection [herpesvirus], inflammatory bowel disease, reactive arthritis, and acidic foods)
|-
|
|Joint disease
|
* Synovitis involving two or more joints, characterized by swelling or effusion '''OR'''
* Tenderness in two or more joints and at least 30 minutes of morning stiffness
|-
|
|Serositis
|
* Typical pleurisy for more than one day, pleural effusions, or pleural rub, '''OR'''
* Typical pericardial pain (pain with recumbency improved by sitting forward) for more than one day, pericardial effusion, pericardial rub, or pericarditis by electrocardiography in the absence of other causes, such as infection, uremia, and Dressler's syndrome
|-
|
|Renal
|
* Urine protein-to-creatinine ratio (or 24-hour urine protein) representing 500 mg protein/24 hours, '''OR'''
* Red blood cell casts
|-
|
|Neurologic
|
* Seizures
* Psychosis
* Mononeuritis multiplex (in the absence of other known causes, such as primary vasculitis)
* Myelitis
* Peripheral or cranial neuropathy (in the absence of other known causes, such as primary vasculitis, infection, and diabetes mellitus) '''OR''' 
* Acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs)
|-
|Hematologic criteria
|Hemolytic anemia
|
|-
|
|Leukopenia or lymphopenia
|Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), '''OR'''
Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection)
|-
|
|Thrombocytopenia
|Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura
|-
|
|ANA
|ANA level above laboratory reference range
|-
|
|Anti-dsDNA
|Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA)
|-
|
|Anit-SM
|Presence of antibody to Sm nuclear antigen
|-
|Immunologic criteria
|Antiphospholipid
|Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM)
|-
|
|Low complement
|Low C3; low C4; '''OR''' low CH50
|-
|
|Direct Coombs' test
|Direct Coombs' test in the absence of hemolytic anemia
|}


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 18:17, 16 June 2017

Systemic lupus erythematosus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Systemic lupus erythematosus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Lupus and Quality of Life

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Systemic lupus erythematosus diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Systemic lupus erythematosus diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Systemic lupus erythematosus diagnostic criteria

on Systemic lupus erythematosus diagnostic criteria

Systemic lupus erythematosus diagnostic criteria in the news

Blogs onSystemic lupus erythematosus diagnostic criteria

Directions to Hospitals Treating Systemic lupus erythematosus

Risk calculators and risk factors for Systemic lupus erythematosus diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

Diagnostic criteria

SLICC criteria for the classification of systemic lupus erythematosus

  1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.
  2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40:1725.
  3. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677.
Criterion Definition
Clinical criteria Acute cutaneous lupus
  • Lupus malar rash (do not count if malar discoid)
  • Bullous lupus
  • Toxic epidermal necrolysis variant of SLE
  • Maculopapular lupus rash
  • Photosensitive lupus rash (in the absence of dermatomyositis); OR subacute cutaneous lupus (nonindurated psoriaform and/or annular polycyclic lesions that resolve without scarring, although occasionally with postinflammatory dyspigmentation or telangiectasias)
Chronic cutaneous lupus
  • Classic discoid rash
    • Localized (above the neck)
    • Generalized (above and below the neck)
    • Hypertrophic (verrucous) lupus
    • Lupus panniculitis (profundus)
    • Mucosal lupus
    • Lupus erythematosus tumidus
    • Chilblains lupus OR
    • Discoid lupus/lichen planus overlap
Nonscarring alopecia
  • Diffuse thinning or hair fragility with visible broken hairs (in the absence of other causes, such as alopecia areata, drugs, iron deficiency, and androgenic alopecia)
Oral or nasal ulcers
  • Palate, buccal, tongue, or nasal ulcers (in the absence of other causes, such as vasculitis, Behçet's disease, infection [herpesvirus], inflammatory bowel disease, reactive arthritis, and acidic foods)
Joint disease
  • Synovitis involving two or more joints, characterized by swelling or effusion OR
  • Tenderness in two or more joints and at least 30 minutes of morning stiffness
Serositis
  • Typical pleurisy for more than one day, pleural effusions, or pleural rub, OR
  • Typical pericardial pain (pain with recumbency improved by sitting forward) for more than one day, pericardial effusion, pericardial rub, or pericarditis by electrocardiography in the absence of other causes, such as infection, uremia, and Dressler's syndrome
Renal
  • Urine protein-to-creatinine ratio (or 24-hour urine protein) representing 500 mg protein/24 hours, OR
  • Red blood cell casts
Neurologic
  • Seizures
  • Psychosis
  • Mononeuritis multiplex (in the absence of other known causes, such as primary vasculitis)
  • Myelitis
  • Peripheral or cranial neuropathy (in the absence of other known causes, such as primary vasculitis, infection, and diabetes mellitus) OR 
  • Acute confusional state (in the absence of other causes, including toxic/metabolic, uremia, drugs)
Hematologic criteria Hemolytic anemia
Leukopenia or lymphopenia Leukopenia (<4000/mm3 at least once) (in the absence of other known causes, such as Felty's syndrome, drugs, and portal hypertension), OR

Lymphopenia (<1000/mm3 at least once) (in the absence of other known causes, such as glucocorticoids, drugs, and infection)

Thrombocytopenia Thrombocytopenia (<100,000/mm3) at least once in the absence of other known causes, such as drugs, portal hypertension, and thrombotic thrombocytopenic purpura
ANA ANA level above laboratory reference range
Anti-dsDNA Anti-dsDNA antibody level above laboratory reference range (or >twofold the reference range if tested by ELISA)
Anit-SM Presence of antibody to Sm nuclear antigen
Immunologic criteria Antiphospholipid Antiphospholipid antibody positivity as determined by any of the following: Positive test result for lupus anticoagulant; false-positive test result for rapid plasma reagin; medium- or high-titer anticardiolipin antibody level (IgA, IgG, or IgM); or positive test result for anti-beta 2-glycoprotein I (IgA, IgG, or IgM)
Low complement Low C3; low C4; OR low CH50
Direct Coombs' test Direct Coombs' test in the absence of hemolytic anemia

References